Bahrain Mirror: Manaf Al-Qahtani, member of the National Medical Taskforce for Combating the Coronavirus, said that Bahrain made an order last August to purchase more than 1 million doses of the COVID-19 vaccines being developed by BioNTech and Pfizer; British firm AstraZeneca and the Chinese Sinopharm. The Kingdom of Bahrain, in cooperation with the United Arab Emirates, participated in the Phase 3 clinical trial for a potential Covid-19 vaccine, being developed by Sinopharm.
Al-Qahtani said that the selection of the vaccines was made by the National Taskforce for Combating COVID-19 after following up on the developments vaccine trials in the world.
He said that Bahrain is in continued contact with the other medical first which are developing the potential COVID-19 vaccine.